 Capucine Van Rechem
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Replication | 8 | 2024 | 251 | 2.180 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 8 | 2021 | 64 | 2.160 |
Why?
| | DNA Replication Timing | 3 | 2022 | 4 | 1.620 |
Why?
| | Lysine | 7 | 2019 | 302 | 1.340 |
Why?
| | Chromatin | 7 | 2022 | 561 | 1.330 |
Why?
| | Protein Biosynthesis | 5 | 2026 | 458 | 1.300 |
Why?
| | Kruppel-Like Transcription Factors | 7 | 2012 | 78 | 1.220 |
Why?
| | Histones | 7 | 2024 | 670 | 1.150 |
Why?
| | SMARCB1 Protein | 1 | 2024 | 34 | 0.850 |
Why?
| | Rhabdoid Tumor | 1 | 2024 | 103 | 0.780 |
Why?
| | Chromosomal Proteins, Non-Histone | 2 | 2022 | 132 | 0.770 |
Why?
| | RNA, Messenger | 4 | 2026 | 2832 | 0.670 |
Why?
| | Glioma | 1 | 2024 | 426 | 0.620 |
Why?
| | Gene Expression Regulation, Neoplastic | 7 | 2026 | 1462 | 0.590 |
Why?
| | Histone Demethylases | 3 | 2014 | 38 | 0.520 |
Why?
| | Methylation | 7 | 2026 | 242 | 0.510 |
Why?
| | Cell Cycle | 6 | 2024 | 597 | 0.510 |
Why?
| | Cell Line, Tumor | 11 | 2026 | 3550 | 0.500 |
Why?
| | Polymorphism, Single Nucleotide | 2 | 2015 | 2147 | 0.500 |
Why?
| | Histone-Lysine N-Methyltransferase | 5 | 2026 | 141 | 0.490 |
Why?
| | Transcription Factors | 6 | 2026 | 1742 | 0.490 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2022 | 451 | 0.460 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2021 | 193 | 0.460 |
Why?
| | Brain Neoplasms | 1 | 2024 | 1322 | 0.450 |
Why?
| | Gene Expression Regulation | 3 | 2020 | 2609 | 0.440 |
Why?
| | Open Reading Frames | 1 | 2015 | 132 | 0.410 |
Why?
| | Neoplasms | 5 | 2022 | 2884 | 0.400 |
Why?
| | Mutation | 3 | 2026 | 4099 | 0.400 |
Why?
| | Nuclear Proteins | 3 | 2026 | 749 | 0.390 |
Why?
| | Alcohol Oxidoreductases | 2 | 2010 | 62 | 0.380 |
Why?
| | S Phase | 3 | 2022 | 80 | 0.370 |
Why?
| | Protein Kinase Inhibitors | 3 | 2019 | 970 | 0.370 |
Why?
| | Cell Line | 7 | 2021 | 2882 | 0.360 |
Why?
| | Histone Code | 2 | 2022 | 39 | 0.350 |
Why?
| | S-Phase Kinase-Associated Proteins | 1 | 2011 | 20 | 0.350 |
Why?
| | Chromatin Immunoprecipitation | 4 | 2022 | 139 | 0.340 |
Why?
| | F-Box Proteins | 1 | 2011 | 23 | 0.340 |
Why?
| | Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 31 | 0.320 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2015 | 883 | 0.310 |
Why?
| | DNA-Binding Proteins | 5 | 2017 | 1500 | 0.310 |
Why?
| | Receptors, CXCR | 1 | 2009 | 5 | 0.300 |
Why?
| | E2F1 Transcription Factor | 1 | 2009 | 68 | 0.290 |
Why?
| | DNA Copy Number Variations | 3 | 2019 | 183 | 0.270 |
Why?
| | Tumor Suppressor Proteins | 1 | 2009 | 321 | 0.250 |
Why?
| | DNA Methylation | 3 | 2026 | 683 | 0.240 |
Why?
| | Promoter Regions, Genetic | 4 | 2019 | 1258 | 0.230 |
Why?
| | RNA Splicing Factors | 1 | 2026 | 65 | 0.230 |
Why?
| | Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2026 | 76 | 0.230 |
Why?
| | Repressor Proteins | 4 | 2012 | 437 | 0.220 |
Why?
| | Sirtuins | 2 | 2019 | 50 | 0.220 |
Why?
| | DNA Helicases | 1 | 2026 | 143 | 0.210 |
Why?
| | Transcription, Genetic | 4 | 2026 | 1496 | 0.210 |
Why?
| | RNA Splicing | 1 | 2026 | 285 | 0.210 |
Why?
| | Humans | 28 | 2026 | 144957 | 0.210 |
Why?
| | Phosphoproteins | 1 | 2026 | 346 | 0.200 |
Why?
| | Phosphatidylinositol 3-Kinases | 2 | 2022 | 381 | 0.200 |
Why?
| | Antineoplastic Agents | 1 | 2015 | 2197 | 0.200 |
Why?
| | Trans-Activators | 3 | 2017 | 405 | 0.200 |
Why?
| | Transcriptome | 3 | 2024 | 1046 | 0.190 |
Why?
| | Base Sequence | 3 | 2011 | 2191 | 0.180 |
Why?
| | Alveolar Epithelial Cells | 1 | 2023 | 120 | 0.180 |
Why?
| | Bromodeoxyuridine | 1 | 2022 | 79 | 0.180 |
Why?
| | Epigenomics | 1 | 2022 | 114 | 0.180 |
Why?
| | Retinoblastoma Binding Proteins | 1 | 2021 | 6 | 0.180 |
Why?
| | Retinal Neoplasms | 1 | 2021 | 37 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 232 | 0.170 |
Why?
| | Retinoblastoma | 1 | 2021 | 42 | 0.170 |
Why?
| | Pluripotent Stem Cells | 1 | 2022 | 84 | 0.170 |
Why?
| | Ribosomes | 1 | 2022 | 191 | 0.170 |
Why?
| | Muscle Proteins | 1 | 2022 | 244 | 0.160 |
Why?
| | Mammals | 1 | 2022 | 293 | 0.160 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2022 | 437 | 0.160 |
Why?
| | Enhancer Elements, Genetic | 1 | 2021 | 192 | 0.160 |
Why?
| | Two-Hybrid System Techniques | 2 | 2010 | 59 | 0.150 |
Why?
| | Sirtuin 1 | 2 | 2010 | 34 | 0.150 |
Why?
| | Animals | 14 | 2023 | 38109 | 0.150 |
Why?
| | Catalysis | 1 | 2020 | 322 | 0.150 |
Why?
| | Transcription Elongation, Genetic | 1 | 2019 | 24 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2023 | 531 | 0.150 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2019 | 10 | 0.150 |
Why?
| | Genome | 1 | 2021 | 306 | 0.150 |
Why?
| | Down-Regulation | 3 | 2011 | 627 | 0.140 |
Why?
| | Sequence Analysis, DNA | 1 | 2022 | 824 | 0.140 |
Why?
| | Retinoblastoma-Binding Protein 2 | 1 | 2018 | 4 | 0.140 |
Why?
| | Epigenesis, Genetic | 2 | 2020 | 685 | 0.140 |
Why?
| | Cell Hypoxia | 2 | 2019 | 247 | 0.140 |
Why?
| | Cell Differentiation | 2 | 2023 | 2050 | 0.140 |
Why?
| | Protein Binding | 3 | 2015 | 2276 | 0.140 |
Why?
| | Methyltransferases | 1 | 2019 | 74 | 0.140 |
Why?
| | Fat Body | 1 | 2017 | 8 | 0.140 |
Why?
| | Colorectal Neoplasms | 1 | 2026 | 848 | 0.130 |
Why?
| | E2F Transcription Factors | 1 | 2017 | 62 | 0.130 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2017 | 69 | 0.130 |
Why?
| | Binding Sites | 2 | 2011 | 1331 | 0.130 |
Why?
| | Gene Expression Profiling | 2 | 2023 | 1786 | 0.130 |
Why?
| | Alleles | 2 | 2023 | 881 | 0.130 |
Why?
| | HEK293 Cells | 5 | 2019 | 744 | 0.120 |
Why?
| | RNA Polymerase II | 1 | 2019 | 351 | 0.120 |
Why?
| | Drosophila Proteins | 1 | 2017 | 212 | 0.120 |
Why?
| | Peptide Initiation Factors | 1 | 2015 | 16 | 0.110 |
Why?
| | Acetylation | 2 | 2019 | 256 | 0.110 |
Why?
| | Hydrazones | 1 | 2015 | 26 | 0.110 |
Why?
| | Peptide Chain Initiation, Translational | 1 | 2015 | 45 | 0.110 |
Why?
| | Cell Proliferation | 3 | 2015 | 2499 | 0.110 |
Why?
| | Ribosomal Proteins | 1 | 2015 | 91 | 0.110 |
Why?
| | Ubiquitination | 1 | 2015 | 118 | 0.110 |
Why?
| | Drug Resistance | 1 | 2015 | 153 | 0.100 |
Why?
| | Aminopyridines | 1 | 2015 | 127 | 0.100 |
Why?
| | Mice | 8 | 2023 | 18365 | 0.100 |
Why?
| | DNA Mutational Analysis | 1 | 2015 | 409 | 0.100 |
Why?
| | Gene Frequency | 1 | 2015 | 481 | 0.100 |
Why?
| | Gene Dosage | 1 | 2013 | 148 | 0.090 |
Why?
| | Protein Processing, Post-Translational | 2 | 2019 | 477 | 0.090 |
Why?
| | Protein Structure, Tertiary | 2 | 2013 | 862 | 0.090 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2012 | 112 | 0.090 |
Why?
| | Histone Deacetylases | 2 | 2011 | 210 | 0.090 |
Why?
| | Receptor, EphA2 | 1 | 2011 | 17 | 0.090 |
Why?
| | Receptors, Adrenergic, beta-2 | 1 | 2011 | 35 | 0.090 |
Why?
| | Databases, Protein | 1 | 2012 | 90 | 0.090 |
Why?
| | Cullin Proteins | 1 | 2011 | 13 | 0.090 |
Why?
| | Ubiquitin | 1 | 2011 | 86 | 0.080 |
Why?
| | Genes, bcl-1 | 1 | 2010 | 1 | 0.080 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2010 | 5 | 0.080 |
Why?
| | Interphase | 1 | 2010 | 38 | 0.080 |
Why?
| | Small Ubiquitin-Related Modifier Proteins | 1 | 2010 | 15 | 0.080 |
Why?
| | DNA | 2 | 2023 | 1464 | 0.080 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2011 | 159 | 0.080 |
Why?
| | Fibroblasts | 3 | 2011 | 1034 | 0.080 |
Why?
| | NIH 3T3 Cells | 1 | 2010 | 148 | 0.080 |
Why?
| | Lung | 1 | 2023 | 4109 | 0.080 |
Why?
| | Lung Neoplasms | 1 | 2023 | 2642 | 0.080 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1958 | 0.080 |
Why?
| | DNA Damage | 1 | 2012 | 430 | 0.080 |
Why?
| | Genes, Neoplasm | 1 | 2009 | 25 | 0.080 |
Why?
| | Cell Adhesion | 2 | 2026 | 455 | 0.070 |
Why?
| | Conserved Sequence | 1 | 2009 | 245 | 0.070 |
Why?
| | Osteosarcoma | 1 | 2009 | 76 | 0.070 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1048 | 0.070 |
Why?
| | Adenoviridae | 1 | 2009 | 199 | 0.070 |
Why?
| | Protein Subunits | 1 | 2009 | 226 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2011 | 453 | 0.070 |
Why?
| | Transcriptional Activation | 1 | 2010 | 383 | 0.070 |
Why?
| | Cell Cycle Proteins | 3 | 2019 | 629 | 0.070 |
Why?
| | Genetic Vectors | 1 | 2009 | 337 | 0.070 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2009 | 758 | 0.060 |
Why?
| | Cell Movement | 1 | 2011 | 965 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2010 | 1371 | 0.060 |
Why?
| | Computational Biology | 1 | 2012 | 681 | 0.060 |
Why?
| | Prognosis | 1 | 2015 | 4293 | 0.060 |
Why?
| | Phylogeny | 1 | 2009 | 1019 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2009 | 2931 | 0.050 |
Why?
| | Mice, Knockout | 2 | 2023 | 3125 | 0.050 |
Why?
| | Cell Self Renewal | 1 | 2023 | 53 | 0.050 |
Why?
| | Models, Biological | 1 | 2010 | 1822 | 0.050 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2023 | 109 | 0.050 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2023 | 253 | 0.050 |
Why?
| | Breast Neoplasms | 2 | 2011 | 2456 | 0.040 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 1 | 2022 | 139 | 0.040 |
Why?
| | Regeneration | 1 | 2023 | 197 | 0.040 |
Why?
| | Cell Lineage | 1 | 2023 | 376 | 0.040 |
Why?
| | Gene Knockdown Techniques | 2 | 2012 | 336 | 0.040 |
Why?
| | Cellular Reprogramming | 1 | 2022 | 103 | 0.040 |
Why?
| | Workflow | 1 | 2022 | 185 | 0.040 |
Why?
| | Embryonic Development | 1 | 2022 | 125 | 0.040 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2022 | 381 | 0.040 |
Why?
| | Disease Progression | 2 | 2023 | 2852 | 0.040 |
Why?
| | RNA Interference | 2 | 2012 | 476 | 0.040 |
Why?
| | Lung Injury | 1 | 2023 | 237 | 0.040 |
Why?
| | Gene Amplification | 1 | 2019 | 121 | 0.040 |
Why?
| | Transcriptional Elongation Factors | 1 | 2019 | 39 | 0.040 |
Why?
| | Amino Acids | 1 | 2022 | 522 | 0.030 |
Why?
| | Heterografts | 1 | 2019 | 144 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2019 | 167 | 0.030 |
Why?
| | Gene Deletion | 1 | 2019 | 389 | 0.030 |
Why?
| | Glucose | 1 | 2022 | 1049 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2019 | 229 | 0.030 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2019 | 339 | 0.030 |
Why?
| | ErbB Receptors | 1 | 2019 | 629 | 0.030 |
Why?
| | Drosophila | 1 | 2017 | 166 | 0.030 |
Why?
| | Cell Division | 1 | 2017 | 766 | 0.030 |
Why?
| | Cells, Cultured | 2 | 2015 | 4155 | 0.030 |
Why?
| | CDC2-CDC28 Kinases | 1 | 2015 | 17 | 0.030 |
Why?
| | Mice, Transgenic | 1 | 2019 | 2185 | 0.020 |
Why?
| | Chromosomes, Human, Pair 1 | 1 | 2013 | 79 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1389 | 0.020 |
Why?
| | Genomic Instability | 1 | 2013 | 66 | 0.020 |
Why?
| | Luciferases | 1 | 2012 | 152 | 0.020 |
Why?
| | Encyclopedias as Topic | 1 | 2012 | 2 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1796 | 0.020 |
Why?
| | Polycomb-Group Proteins | 1 | 2012 | 36 | 0.020 |
Why?
| | Genes, Reporter | 1 | 2012 | 276 | 0.020 |
Why?
| | Zinc Fingers | 1 | 2012 | 53 | 0.020 |
Why?
| | Enhancer of Zeste Homolog 2 Protein | 1 | 2012 | 56 | 0.020 |
Why?
| | Proteomics | 1 | 2019 | 1195 | 0.020 |
Why?
| | Access to Information | 1 | 2012 | 48 | 0.020 |
Why?
| | Insulin | 1 | 2022 | 2507 | 0.020 |
Why?
| | Mammary Glands, Human | 1 | 2011 | 67 | 0.020 |
Why?
| | Polycomb Repressive Complex 2 | 1 | 2012 | 82 | 0.020 |
Why?
| | Gene Silencing | 1 | 2011 | 205 | 0.020 |
Why?
| | Zebrafish | 1 | 2015 | 528 | 0.020 |
Why?
| | Pancreatic Neoplasms | 1 | 2019 | 927 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2011 | 509 | 0.020 |
Why?
| | Cerebellum | 1 | 2012 | 223 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2011 | 695 | 0.020 |
Why?
| | HeLa Cells | 1 | 2010 | 650 | 0.020 |
Why?
| | Neoplasm Proteins | 1 | 2012 | 444 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 940 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 737 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2019 | 5997 | 0.020 |
Why?
| | Caenorhabditis elegans | 1 | 2010 | 337 | 0.020 |
Why?
| | Internet | 1 | 2012 | 700 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2010 | 1173 | 0.020 |
Why?
| | Signal Transduction | 1 | 2019 | 5233 | 0.010 |
Why?
| | Rats | 1 | 2012 | 5614 | 0.010 |
Why?
| | Female | 3 | 2019 | 78376 | 0.010 |
Why?
| | Aged | 1 | 2019 | 25947 | 0.010 |
Why?
| | Adult | 1 | 2019 | 40506 | 0.010 |
Why?
| | Male | 1 | 2019 | 72406 | 0.010 |
Why?
|
|
Van Rechem's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|